Sök på Folkhälsomyndighetens webbplats

Personlig skyddsutrustning såsom skyddshandskar, skyddskläder och andningsskydd utgör primär barriär för den som hanterar smittförande material samt förhindrar att smitta följer med ut från det kontrollerade området.

The Public Health Agency of Sweden has developed this guidance to support the monitoring of travellers returning to Sweden from countries with active cases of haemorrhagic fever such as Ebola or Marburg.

Since 1997, the Public Health Agency of Sweden has conducted an Enhanced pertussis surveillance (EPS) of children with pertussis in Sweden. Part of the surveillance includes clinical information and vaccination histories. The methods used in the article are described in more detail in this

Vägledningen gäller i en epidemiologisk situation med få fall av fågelinfluensa hos människa och där smittkällan är sjuka eller döda fåglar.

This report present a short description of a framework for how the reformulated public health strategy will be implemented.

Rapport från en arbetsgrupp med representanter från smittskydd och vårdhygien 2016-2017.

Swedres-Svarm 2019 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary Institute (SVA).

Fördjupad information om hur smittämnen överförs och hur man genom en god handhygien kan förhindra smittspridning. Broschyren är avsedd för vård- och omsorgspersonal.

Rapporten sammanfattar kunskap och föreslår förebyggande åtgärder, åtgärder för övervakning samt hantering av utbrott orsakade av Clostridioides difficile.

This report is primarily written for health care professionals, particularly those working in maternal and child health care, school health care, primary care, and those working in the counties’ Departments of Communicable Disease Control and Prevention as well as public health officials and authorities…

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

This report summarizes the influenza A(H1N1)2009 pandemic in Sweden between April 24, 2009 and May 23, 2010. The report is based on data from the various surveillance systems used during the pandemic. The systems are presented in some detail to facilitate the reader’s understanding of the quality

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The recommendations for children up to 12 years of age are primarily aimed at parents and other adults who meet the children in their everyday life.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

Swedres-Svarm 2012 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary Institute (SVA).

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

Ett kunskapsunderlag som handlar om hur man förebygger infektioner hos patienter och personal i hälso- och sjukvården och tandvården. Bygger på aktuell kunskap och forskning.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The Public Health Agency of Sweden has updated the recommendations for mpox vaccination due to increased spread of clade 1.

This report describes a health economic evaluation that investigates the potential cost-effectiveness of an extension of the national vaccination programme for children against human papilloma virus to also include boys. Today, only girls are offered vaccination within the national vaccination